Applications of 3D Cell Culture in Biomedicines

A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Molecular and Translational Medicine".

Deadline for manuscript submissions: 30 November 2024 | Viewed by 1665

Special Issue Editor

E-Mail Website
Guest Editor
Department of Maternal-Fetal Biology, National Research Institute for Child Health and Development, Tokyo, Japan
Interests: cell therapy; regenerative therapy; cell biotechnology; 3D culture; nanoparticles; bioimaging; biobank; cryopreservation; stem cell; health technology assessment
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

In recent years, research on the fabrication and application of living tissues and organs has been widely conducted using 3D culture (three-dimensional culture) techniques. For example, materials such as ECM (extracellular matrix) and synthetic polymers can be microfabricated to provide a favorable environment and scaffold for individual cells. In other words, a culture environment similar to a living organism (in vivo) can be reconstructed in vitro and created using MEMS (micro electro mechanical system) technology. In addition, it has been possible to induce pluripotent cells (ES cells and iPS cells) and tissue stem cells into target 3D models (brain, liver, skin, bone, cornea, cartilage, cancer, etc.) by improving culture methods and conditions. The obtained tissues and organs are expected to be applied in many fields of biomedicine, regenerative therapy, and drug discovery. Here, we call for reports on 'Applications of 3D Cell Culture in Biomedicines' in various fields of biomedicines. Examples of topics of interest include:

  • 3D cultures (culture technology, biomaterials, culture device, culture device design, simulation, etc.).
  • 3D tissue and organs (biomedicine, regenerative therapy, and drug discovery, in vitro, in vivo, ex vivo).

Therefore, this Special Issue seeks to publish high-quality articles, including original research and reviews.

Dr. Yoshitaka Miyamoto
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.


  • 3D cell culture
  • organoid
  • spheroid
  • stem cell
  • transplantation
  • scaffold
  • extracellular matrix
  • biomedicine
  • regenerative therapy
  • drug discovery

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:


14 pages, 5975 KiB  
A Platform for Testing the Biocompatibility of Implants: Silicone Induces a Proinflammatory Response in a 3D Skin Equivalent
by Rima Nuwayhid, Torsten Schulz, Frank Siemers, Jeannine Schreiter, Philipp Kobbe, Gunther Hofmann, Stefan Langer and Olga Kurow
Biomedicines 2024, 12(1), 224; - 19 Jan 2024
Viewed by 974
Biocompatibility testing of materials is carried out in 2D cell cultures or animal models despite serious limitations. 3D skin equivalents are advanced in vitro models for human skin. Silicone has been shown to be noncytotoxic but capable of eliciting an immune response. Our [...] Read more.
Biocompatibility testing of materials is carried out in 2D cell cultures or animal models despite serious limitations. 3D skin equivalents are advanced in vitro models for human skin. Silicone has been shown to be noncytotoxic but capable of eliciting an immune response. Our aim was to (1) establish a 3D skin equivalent to (2) assess the proinflammatory properties of silicone. We developed a coculture of keratinocytes and fibroblasts resulting in a 3D skin equivalent with an implant using samples from a breast implant. Samples with and without the silicone implant were studied histologically and immunohistochemically in comparison to native human skin samples. Cytotoxicity was assessed via LDH-assay, and cytokine response was assessed via ELISA. Histologically, our 3D skin equivalents had a four-layered epidermal and a dermal component. The presence of tight junctions was demonstrated in immunofluorescence. The only difference in 3D skin equivalents with implants was an epidermal thinning. Implanting the silicone samples did not cause more cell death, however, an inflammatory cytokine response was triggered. We were able to establish an organotypical 3D skin equivalent with an implant, which can be utilised for studies on biocompatibility of materials. This first integration of silicone into a 3D skin equivalent confirmed previous findings on silicone being non-cell-toxic but capable of exerting a proinflammatory effect. Full article
(This article belongs to the Special Issue Applications of 3D Cell Culture in Biomedicines)
Show Figures

Figure 1

Back to TopTop